Top 10 Cancer Keys and resources from 2021

17th December 2021

As the year comes to an end, we have gathered our top 10 Cancer Keys and resources from 2021.

  1. How many COVID vaccines do people with cancer need?

People who might have been immunosuppressed at the time of their first two vaccine doses are eligible to receive a third primary dose. Learn more about how many COVID vaccines people with cancer need here.

  1. The Cancer Maps – an interactive NICE NG12 guidance reference tool

The Cancer Maps, created by Dr Ben Noble, have been updated to improve their functionality and visual appearance.

New features include:

  • Background and risk factor information about each cancer type
  • Links to relevant GatewayC courses
  • Important false-negative figures for key investigations

Learn more about The Cancer Maps here.

  1. Could you spot bowel cancer in younger patients?

Younger patients often do not fit the criteria for a suspected cancer pathway referral. However, every year over 2,500 younger people are diagnosed with bowel cancer in the UK. Learn about the issues of identifying bowel cancer in younger patients here.

  1. PSA request from a patient – What should you consider?

The PSA test is not specific to prostate cancer and can be affected by many factors. Many patients request a test, but it is important that they are aware of the pros and cons of the test. Read what to consider when discussing a PSA test with a patient here.

  1. Assessing peripheral neuropathy

It is important for primary care practitioners to explore and assess peripheral neuropathy carefully by evaluating the level of impact on the patient, both physically and emotionally. Learn more and access GatewayC’s ‘Managing Physical Effects’ course here.

  1. Ovarian cancer and persistent bloating

Persistent bloating is a common presenting symptom of ovarian cancer. Therefore, a potential missed diagnostic opportunity can occur if this is not investigated. We summarised the NICE NG12 guidance here.

  1. Myeloma and C.R.A.B

C.R.A.B is the acronym designed to simplify the most typical clinical manifestations of multiple myeloma. Learn more about the C.R.A.B acronym and direct links to NICE NG12 guidance here.

  1. How reliable is the CA125?

While the CA125 blood test is useful for diagnosing and monitoring people with ovarian cancer, 25% of ​patients with ovarian cancers will have a normal CA125 level. Explore key learnings here.

  1. New-onset diabetes and pancreatic cancer

Diabetes, especially Type 2, is common among the general population. However, unexplained new-onset diabetes should be investigated as a possible indicator of pancreatic cancer. We summarised the NICE NG12 guidance here.

  1. 5 tips to treat infection and lymphoedema

Lymphoedema may affect one or more limbs and corresponding quadrants of the trunk, face, breast, and genitals. Read our guidance on how to treat infection and lymphoedema here.

Find out more:

  • Find all Cancer Keys published here
  • Find GatewayC Live’s upcoming and on-demand webinars here

LinkedIn | Twitter | Facebook

Latest from the Blog

Can blood tests identify lung cancer?

Can blood tests identify lung cancer?

14th June 2022 A Full Blood Count (FBC) can help to identify cancer, but normal test results do not exclude the possibility of cancer. There are a number of test results which should be of concern, including: Anaemia Raised platelets Abnormal liver function Many...

read more

Related Posts

New course: Skin Cancer – Early Diagnosis

New course: Skin Cancer – Early Diagnosis

4th May 2022 The GatewayC team are pleased to announce that we have a new course ‘Skin Cancer – Early Diagnosis’ available to all healthcare professionals on GatewayC. Skin cancer is the most common type of cancer and is increasing in incidence in the UK. Skin cancers...

read more
Dr Sarah Taylor’s top picks

Dr Sarah Taylor’s top picks

3rd March 2022 I have listed below my top picks of GatewayC’s online courses and on-demand webinars. I thought this would be helpful if you’re looking to top up your CPD this month. Please do share this email with your colleagues. If they aren’t registered with...

read more